Stanford spinout Cardinal Analytx has raised $20.6m out of a targeted $29.3m, adding to a $6.1m series A round backed by Stanford-StartX Fund in 2017.
Cardinal Analytx, a US-based population health management spinout of Stanford University, has obtained $20.6m in initial series B funding from undisclosed backers, according to a regulatory filing.
The company is targeting a $29.3m final close but has not yet made any formal announcements.
Founded in 2013, Cardinal Analytx has developed machine learning and artificial intelligence technology that predicts which health insurance customers are high risk, recommending clinical interventions to improve patient outcome and prevent costs from rising.
…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
